Repeat endocarditis: Analysis of risk factors based on the International collaboration on endocarditis - Prospective cohort study

L. Alagna; L. P. Park; B. P. Nicholson; A. J. Keiger; J. Strahilevitz; A. Morris; D. Wray; D. Gordon; F. Delahaye; J. Edathodu; J. M. Miró; N. Fernández-Hidalgo; F. M. Nacinovich; R. Shahid; C. W. Woods; M. J. Joyce; D. J. Sexton; V. H. Chu

doi:10.1111/1469-0691.12395

Repeat endocarditis: Analysis of risk factors based on the International collaboration on endocarditis - Prospective cohort study

L. Alagna^*, L. P. Park, B. P. Nicholson, A. J. Keiger, J. Strahilevitz, A. Morris, D. Wray, D. Gordon, F. Delahaye, J. Edathodu, J. M. Miró, N. Fernández-Hidalgo, F. M. Nacinovich, R. Shahid, C. W. Woods, M. J. Joyce, D. J. Sexton, V. H. Chu

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

82 Scopus citations

Abstract

Repeat episodes of infective endocarditis (IE) can occur in patients who survive an initial episode. We analysed risk factors and 1-year mortality of patients with repeat IE. We considered 1874 patients enrolled in the International Collaboration on Endocarditis - Prospective Cohort Study between January 2000 and December 2006 (ICE-PCS) who had definite native or prosthetic valve IE and 1-year follow-up. Multivariable analysis was used to determine risk factors for repeat IE and 1-year mortality. Of 1874 patients, 1783 (95.2%) had single-episode IE and 91 (4.8%) had repeat IE: 74/91 (81%) with new infection and 17/91 (19%) with presumed relapse. On bivariate analysis, repeat IE was associated with haemodialysis (p 0.002), HIV (p 0.009), injection drug use (IDU) (p < 0.001), Staphylococcus aureus IE (p 0.003), healthcare acquisition (p 0.006) and previous IE before ICE enrolment (p 0.001). On adjusted analysis, independent risk factors were haemodialysis (OR, 2.5; 95% CI, 1.2-5.3), IDU (OR, 2.9; 95% CI, 1.6-5.4), previous IE (OR, 2.8; 95% CI, 1.5-5.1) and living in the North American region (OR, 1.9; 95% CI, 1.1-3.4). Patients with repeat IE had higher 1-year mortality than those with single-episode IE (p 0.003). Repeat IE is associated with IDU, previous IE and haemodialysis. Clinicians should be aware of these risk factors in order to recognize patients who are at risk of repeat IE.

Original language	English
Pages (from-to)	566-575
Number of pages	10
Journal	Clinical Microbiology and Infection
Volume	20
Issue number	6
DOIs	https://doi.org/10.1111/1469-0691.12395
State	Published - Jun 2014
Externally published	Yes

Bibliographical note

Funding Information:
We would like to acknowledge the support given to this project from all of the personnel at each site and at the coordinating centre and Dr Scarpellini Paolo MD for mentorship during this project period. This work was supported in part by grants from the American Heart Association 0675027N (VHC) and the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), Fondo de Investigaciones Sanitarias (FIS) (Madrid, Spain) grants FIS 05/0170 and FIS 080268 and Fundacion Maximo Soriano Jiménez (Barcelona, Spain). J.M.M. held during 2011 an INT10/219 Intensification Research Grant (I3SNS & PRICS programmes) from the Instituto de Salud Carlos III, Madrid (Spain) and the Departament de Salut de la Generalitat de Catalunya, Barcelona (Spain).

Keywords

Complication of endocarditis
Recurrence of endocarditis
Relapse of endocarditis
Repeat endocarditis
Risk factors for endocarditis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/1469-0691.12395

Cite this

Alagna, L., Park, L. P., Nicholson, B. P., Keiger, A. J., Strahilevitz, J., Morris, A., Wray, D., Gordon, D., Delahaye, F., Edathodu, J., Miró, J. M., Fernández-Hidalgo, N., Nacinovich, F. M., Shahid, R., Woods, C. W., Joyce, M. J., Sexton, D. J., & Chu, V. H. (2014). Repeat endocarditis: Analysis of risk factors based on the International collaboration on endocarditis - Prospective cohort study. Clinical Microbiology and Infection, 20(6), 566-575. https://doi.org/10.1111/1469-0691.12395

@article{589f5c1d78544ed49f672cc4bdf676b2,

title = "Repeat endocarditis: Analysis of risk factors based on the International collaboration on endocarditis - Prospective cohort study",

abstract = "Repeat episodes of infective endocarditis (IE) can occur in patients who survive an initial episode. We analysed risk factors and 1-year mortality of patients with repeat IE. We considered 1874 patients enrolled in the International Collaboration on Endocarditis - Prospective Cohort Study between January 2000 and December 2006 (ICE-PCS) who had definite native or prosthetic valve IE and 1-year follow-up. Multivariable analysis was used to determine risk factors for repeat IE and 1-year mortality. Of 1874 patients, 1783 (95.2%) had single-episode IE and 91 (4.8%) had repeat IE: 74/91 (81%) with new infection and 17/91 (19%) with presumed relapse. On bivariate analysis, repeat IE was associated with haemodialysis (p 0.002), HIV (p 0.009), injection drug use (IDU) (p < 0.001), Staphylococcus aureus IE (p 0.003), healthcare acquisition (p 0.006) and previous IE before ICE enrolment (p 0.001). On adjusted analysis, independent risk factors were haemodialysis (OR, 2.5; 95% CI, 1.2-5.3), IDU (OR, 2.9; 95% CI, 1.6-5.4), previous IE (OR, 2.8; 95% CI, 1.5-5.1) and living in the North American region (OR, 1.9; 95% CI, 1.1-3.4). Patients with repeat IE had higher 1-year mortality than those with single-episode IE (p 0.003). Repeat IE is associated with IDU, previous IE and haemodialysis. Clinicians should be aware of these risk factors in order to recognize patients who are at risk of repeat IE.",

keywords = "Complication of endocarditis, Recurrence of endocarditis, Relapse of endocarditis, Repeat endocarditis, Risk factors for endocarditis",

author = "L. Alagna and Park, {L. P.} and Nicholson, {B. P.} and Keiger, {A. J.} and J. Strahilevitz and A. Morris and D. Wray and D. Gordon and F. Delahaye and J. Edathodu and Mir{\'o}, {J. M.} and N. Fern{\'a}ndez-Hidalgo and Nacinovich, {F. M.} and R. Shahid and Woods, {C. W.} and Joyce, {M. J.} and Sexton, {D. J.} and Chu, {V. H.}",

note = "Funding Information: We would like to acknowledge the support given to this project from all of the personnel at each site and at the coordinating centre and Dr Scarpellini Paolo MD for mentorship during this project period. This work was supported in part by grants from the American Heart Association 0675027N (VHC) and the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), Fondo de Investigaciones Sanitarias (FIS) (Madrid, Spain) grants FIS 05/0170 and FIS 080268 and Fundacion Maximo Soriano Jim{\'e}nez (Barcelona, Spain). J.M.M. held during 2011 an INT10/219 Intensification Research Grant (I3SNS & PRICS programmes) from the Instituto de Salud Carlos III, Madrid (Spain) and the Departament de Salut de la Generalitat de Catalunya, Barcelona (Spain). ",

year = "2014",

month = jun,

doi = "10.1111/1469-0691.12395",

language = "אנגלית",

volume = "20",

pages = "566--575",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

number = "6",

}

Alagna, L, Park, LP, Nicholson, BP, Keiger, AJ, Strahilevitz, J, Morris, A, Wray, D, Gordon, D, Delahaye, F, Edathodu, J, Miró, JM, Fernández-Hidalgo, N, Nacinovich, FM, Shahid, R, Woods, CW, Joyce, MJ, Sexton, DJ & Chu, VH 2014, 'Repeat endocarditis: Analysis of risk factors based on the International collaboration on endocarditis - Prospective cohort study', Clinical Microbiology and Infection, vol. 20, no. 6, pp. 566-575. https://doi.org/10.1111/1469-0691.12395

TY - JOUR

T1 - Repeat endocarditis

T2 - Analysis of risk factors based on the International collaboration on endocarditis - Prospective cohort study

AU - Alagna, L.

AU - Park, L. P.

AU - Nicholson, B. P.

AU - Keiger, A. J.

AU - Strahilevitz, J.

AU - Morris, A.

AU - Wray, D.

AU - Gordon, D.

AU - Delahaye, F.

AU - Edathodu, J.

AU - Miró, J. M.

AU - Fernández-Hidalgo, N.

AU - Nacinovich, F. M.

AU - Shahid, R.

AU - Woods, C. W.

AU - Joyce, M. J.

AU - Sexton, D. J.

AU - Chu, V. H.

N1 - Funding Information: We would like to acknowledge the support given to this project from all of the personnel at each site and at the coordinating centre and Dr Scarpellini Paolo MD for mentorship during this project period. This work was supported in part by grants from the American Heart Association 0675027N (VHC) and the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), Fondo de Investigaciones Sanitarias (FIS) (Madrid, Spain) grants FIS 05/0170 and FIS 080268 and Fundacion Maximo Soriano Jiménez (Barcelona, Spain). J.M.M. held during 2011 an INT10/219 Intensification Research Grant (I3SNS & PRICS programmes) from the Instituto de Salud Carlos III, Madrid (Spain) and the Departament de Salut de la Generalitat de Catalunya, Barcelona (Spain).

PY - 2014/6

Y1 - 2014/6

N2 - Repeat episodes of infective endocarditis (IE) can occur in patients who survive an initial episode. We analysed risk factors and 1-year mortality of patients with repeat IE. We considered 1874 patients enrolled in the International Collaboration on Endocarditis - Prospective Cohort Study between January 2000 and December 2006 (ICE-PCS) who had definite native or prosthetic valve IE and 1-year follow-up. Multivariable analysis was used to determine risk factors for repeat IE and 1-year mortality. Of 1874 patients, 1783 (95.2%) had single-episode IE and 91 (4.8%) had repeat IE: 74/91 (81%) with new infection and 17/91 (19%) with presumed relapse. On bivariate analysis, repeat IE was associated with haemodialysis (p 0.002), HIV (p 0.009), injection drug use (IDU) (p < 0.001), Staphylococcus aureus IE (p 0.003), healthcare acquisition (p 0.006) and previous IE before ICE enrolment (p 0.001). On adjusted analysis, independent risk factors were haemodialysis (OR, 2.5; 95% CI, 1.2-5.3), IDU (OR, 2.9; 95% CI, 1.6-5.4), previous IE (OR, 2.8; 95% CI, 1.5-5.1) and living in the North American region (OR, 1.9; 95% CI, 1.1-3.4). Patients with repeat IE had higher 1-year mortality than those with single-episode IE (p 0.003). Repeat IE is associated with IDU, previous IE and haemodialysis. Clinicians should be aware of these risk factors in order to recognize patients who are at risk of repeat IE.

AB - Repeat episodes of infective endocarditis (IE) can occur in patients who survive an initial episode. We analysed risk factors and 1-year mortality of patients with repeat IE. We considered 1874 patients enrolled in the International Collaboration on Endocarditis - Prospective Cohort Study between January 2000 and December 2006 (ICE-PCS) who had definite native or prosthetic valve IE and 1-year follow-up. Multivariable analysis was used to determine risk factors for repeat IE and 1-year mortality. Of 1874 patients, 1783 (95.2%) had single-episode IE and 91 (4.8%) had repeat IE: 74/91 (81%) with new infection and 17/91 (19%) with presumed relapse. On bivariate analysis, repeat IE was associated with haemodialysis (p 0.002), HIV (p 0.009), injection drug use (IDU) (p < 0.001), Staphylococcus aureus IE (p 0.003), healthcare acquisition (p 0.006) and previous IE before ICE enrolment (p 0.001). On adjusted analysis, independent risk factors were haemodialysis (OR, 2.5; 95% CI, 1.2-5.3), IDU (OR, 2.9; 95% CI, 1.6-5.4), previous IE (OR, 2.8; 95% CI, 1.5-5.1) and living in the North American region (OR, 1.9; 95% CI, 1.1-3.4). Patients with repeat IE had higher 1-year mortality than those with single-episode IE (p 0.003). Repeat IE is associated with IDU, previous IE and haemodialysis. Clinicians should be aware of these risk factors in order to recognize patients who are at risk of repeat IE.

KW - Complication of endocarditis

KW - Recurrence of endocarditis

KW - Relapse of endocarditis

KW - Repeat endocarditis

KW - Risk factors for endocarditis

UR - http://www.scopus.com/inward/record.url?scp=84904420479&partnerID=8YFLogxK

U2 - 10.1111/1469-0691.12395

DO - 10.1111/1469-0691.12395

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 24102907

AN - SCOPUS:84904420479

SN - 1198-743X

VL - 20

SP - 566

EP - 575

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 6

ER -

Repeat endocarditis: Analysis of risk factors based on the International collaboration on endocarditis - Prospective cohort study

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this